HIV-1 matrix protein binding to RNA

Journal of Molecular Biology

Volumn 410, Issue 4, 2011, Pages 653-666

  Alfadhli, Ayna ^a   McNett, Henry ^a   Tsagli, Seyram ^a   Bächinger, Hans Peter ^a   Peyton, David H ^b   Barklis, Eric ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

Author keywords

Gag; Human immunodeficiency virus type 1; Matrix; Nuclear magnetic resonance; Phosphatidylinositol (4,5) bisphosphate

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS 1 MATRIX PROTEIN; MATRIX PROTEIN; RNA; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; FLUORESCENCE; GEL MOBILITY SHIFT ASSAY; MEMBRANE BINDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RNA BINDING; ULTRACENTRIFUGATION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051766523     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.04.063     Document Type: Article

References (61)

1. Mervis, R., Ahmad, N., Lillehij, E., Raum, M., Salazar, F., Chan, H. & Venkatesan, S. (1988). The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62, 3993-4002.
2. Bryant, M. & Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad. Sci. USA, 87, 523-527.
3. Tritel, M. & Resh, M. D. (2000). Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates. J. Virol. 74, 5845-5855. (Pubitemid 30412952)
4. Swanstrom, R. & Wills, J. (1997). Synthesis, assembly and processing of viral proteins. In Retroviruses (Coffin, J., Hughes, S. & Varmus, H., eds), pp. 263-334, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
5. Freed, E. (1998). HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology, 251, 1-15. (Pubitemid 28527713)
6. Bhatia, A., Campbell, N., Panganiban, A. & Ratner, L. (2007). Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix. Virology, 369, 47-54. (Pubitemid 350029866)
7. Bouamr, F., Scarlata, S. & Carter, C. (2003). Role of myristoylation in HIV-1 Gag assembly. Biochemistry, 42, 6408-6417. (Pubitemid 36665815)
8. Dalton, A., Ako-Adjei, D., Murray, P., Murray, D. & Vogt, V. (2007). Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81, 6434-6445. (Pubitemid 46878049)
9. Ehrlich, L., Fong, S., Scarlata, S., Zybarth, G. & Carter, C. (1996). Partitioning of HIV-1 Gag and Gag-related proteins to membranes. Biochemistry, 35, 3933-3943. (Pubitemid 26113447)
10. Jouvenet, N., Neil, S., Bess, C., Johnson, M., Virgen, C., Simon, S. & Bieniasz, P. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4, 2296-2310. (Pubitemid 44917619)
11. Morikawa, Y., Hockley, D., Nermut, M. & Jones, I. (2000). Roles of the matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J. Virol. 74, 16-23. (Pubitemid 30002878)
12. Murray, P., Li, L., Wang, J., Tang, C., Honig, B. & Murray, D. (2005). Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure, 13, 1521-1531. (Pubitemid 41427591)
13. Scarlata, S., Ehrlich, L. & Carter, C. (1998). Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J. Mol. Biol. 277, 161-167.
14. Scholz, I., Still, A., Dhenub, T., Coday, K., Webb, M. & Barklis, E. (2008). Analysis of human immunodeficiency virus matrix domain replacements. Virology, 371, 322-335. (Pubitemid 351173235)
15. Spearman, P., Wang, J., Vander Heyden, N. & Ratner, L. (1994). Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68, 3232-3242. (Pubitemid 24129773)
16. Yu, X., Yuan, X., Matsuda, Z., Lee, T. H. & Essex, M. (1992). The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66, 4966-4971.
17. Davis, M., Jiang, J., Zhou, J., Freed, E. & Aiken, C. (2006). A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of envelope protein subunits gp120 and gp41. J. Virol. 80, 2405-2417. (Pubitemid 43271546)
18. Dorfman, T., Mammano, F., Haseltine, W. & Gottlinger, H. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696. (Pubitemid 24065736)
19. Freed, E. & Martin, M. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989.
20. Freed, E. & Martin, M. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope and incorporation into virions. J. Virol. 70, 341-351. (Pubitemid 126508804)
21. Gag in immature human immunodeficiency virus type1 particles. J. Virol. 74, 9381-9387.
22. Ott, D., Coren, L. & Gagliardi, T. (2005). Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly. J. Virol. 79, 13839-13847. (Pubitemid 41552682)
23. Purohit, P., Dupont, S., Stevenson, M. & Green, M. (2001). Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA, 4, 576-584. (Pubitemid 32416815)
24. Lochrie, M., Waugh, S., Pratt, D., Clever, J., Parslow, T. & Polisky, B. (1997). In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res. 25, 2902-2910. (Pubitemid 27299809)
25. Alfadhli, A., Still, A. & Barklis, E. (2009). Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J. Virol. 83, 12196-12203.
26. Chukkapalli, V., Oh, S. J. & Ono, A. (2010). Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl Acad. Sci. USA, 107, 1600-1605.
27. Monde, K., Chukkapalli, V. & Ono, A. (2011). Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate. J. Virol. 85, 3584-3595.
28. Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A., Spitz, L. et al. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature, 365, 666-669. (Pubitemid 23350541)
29. Von Schwedler, U., Kornbluth, R. & Trono, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl Acad. Sci. USA, 91, 6992-6996. (Pubitemid 24226788)
30. Miller, M. D., Farnet, C. M. & Bushman, F. (1997). Human immunodeficiency virus type 1 preintegra-tion complexes: studies of organization and composition. J. Virol. 71, 5382-5390. (Pubitemid 27258214)
31. Reil, H., Bukovsky, A., Gelderblom, H. R. & Göttlinger, H. G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708. (Pubitemid 28221204)
32. Haffar, O. K., Popov, S., Dubrovsky, L., Agostini, I., Tang, H., Pushkarsky, T. et al. (2000). Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299, 359-368.
33. Hearps, A. C., Wagstaff, K. M., Piller, S.C. & Jans, D.A. (2008). The N-terminal basic domain of the HIV-1 matrix protein does not contain a conventional nuclear localization sequence but is required for DNA binding and protein self-association. Biochemistry, 47, 2199-2210. (Pubitemid 351287146)
34. Cai, M., Huang, Y., Craigie, R. & Clore, G. M. (2010). Structural basis of the association of HIV-1 matrix protein with DNA. PLoS One, 5, e15675.
35. Massiah, M. A., Starich, M. R., Paschall, C. & Summers, M. F. (1994). Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244, 198-223. (Pubitemid 24366038)
36. Hill, C., Worthylake, D., Bancroft, D., Christensen, A. & Sundquist, W. (1996). Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA, 93, 3099-3104. (Pubitemid 26114370)
37. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D. & Summers, M. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA, 101, 517-522. (Pubitemid 38084668)
38. Saad, J., Miller, J., Tai, J., Kim, A., Ghanum, R. & Summers, M. (2006). Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA, 103, 11364-11369. (Pubitemid 44156523)
39. Saad, J., Loeliger, E., Luncsford, P., Liriano, M., Tai, J., Kim, A. et al. (2007). Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J. Mol. Biol. 366, 574-585. (Pubitemid 46136215)
40. Göttlinger, H. G., Sodroski, J. G. & Haseltine, W. A. (1989). Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 86, 5781-5785. (Pubitemid 19217537)
41. Spearman, P., Wang, J. J., Vander Heyden, N. & Ratner, L. (1994). Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68, 3232-3242. (Pubitemid 24129773)
42. Chukkapalli, V., Hogue, I., Boyko, V., Hu, W. & Ono, A. (2008). Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding. J. Virol. 82, 2405-2417. (Pubitemid 351293541)
43. Ono, A., Ablan, S., Lockett, S., Nagashima, K. & Freed, E. (2004). Phosphatidyl (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA, 101, 14889-14894. (Pubitemid 39410770)
44. Alfadhli, A., Barklis, R. & Barklis, E. (2009). HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol- (4,5)-bispho-sphate. Virology, 387, 466-472.
45. Cimarelli, A. & Luban, J. (1999). Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polypro-tein. J. Virol. 73, 5388-5401. (Pubitemid 29274821)
46. Chang, C. Y., Chang, Y. F., Wang, S. M., Tseng, Y. T. & Wang, C. T. (2008). HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly. Virology, 378, 97-104.
47. Jones, C. P., Datta, S. A., Rein, A., Rouzina, I. & Musier-Forsyth, K. (2011). HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J. Mol. Biol. 406, 205-214.
48. Datta, S., Zhao, P., Clark, S., Tarasov, J., Alexandratos, S., Campbell, M. et al. (2007). Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365, 799-811. (Pubitemid 44960371)
49. Datta, S., Curtis, W., Ratcliff, P., Clark, R., Crist, J., Lebowitz, S. et al. (2007). Conformation of the HIV-1 Gag protein in solution. J. Mol. Biol. 365, 812-824. (Pubitemid 44960372)
50. Wang, C. T. & Barklis, E. (1993). Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67, 4264-4273. (Pubitemid 23180753)
51. Alfadhli, A., Dhenub, T. C., Still, A. & Barklis, E. (2005). Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly. J. Virol. 79, 14498-14506. (Pubitemid 41636248)
52. Alfadhli, A., Huseby, D., Kapit, E., Colman, D. & Barklis, E. (2007). Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 81, 1472-1478. (Pubitemid 46167868)
53. Barklis, E., Alfadhli, A., McQuaw, C., Yalamuri, S., Still, A., Barklis, R. et al. (2009). Characterization of the in vitro HIV-1 capsid assembly pathway. J. Mol. Biol, 387, 376-389.
54. Wang, C. T., Zhang, Y., McDermott, J. & Barklis, E. (1993). Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J. Virol. 67, 7067-7076. (Pubitemid 23343832)
55. Zuber, G., McDermott, J., Karanjia, S., Zhao, W., Schmid, M. F. & Barklis, E. (2000). Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. J. Virol. 74, 7431-7441. (Pubitemid 30613088)
56. Lundblad, J. R., Laurance, M. & Goodman, R. H. (1996). Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol. Endocrinol. 10, 607-612. (Pubitemid 26176268)
57. Perkins, S. J. (1986). Protein volumes and hydration effects. The calculations of partial specific volumes, neutron scattering matchpoints and 280-nm absorption coefficients for proteins and glycoproteins from amino acid sequences. Eur. J. Biochem. 157, 169-180.
58. Alfadhli, A., Steel, E., Finlay, L., Bächinger, H. P. & Barklis, E. (2002). Hantavirus nucleocapsid protein coiled-coil domains. J. Biol. Chem. 277, 27103-27108. (Pubitemid 34951724)
59. Zhou, J., McAllen, J., Tailor, Y. & Summers, M. F. (2005). High affinity nucleocapsid protein binding to the μψ RNA packaging signal of Rous sarcoma virus. J. Mol. Biol. 349, 976-988. (Pubitemid 40779620)
60. Johnson, B. A. & Blevins, R. A. (1994). NMR View: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR, 4, 603-614.
61. Davis, A. L., Keeler, J., Laue, E. D. & Moskau, D. (1992). Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients. J. Magn. Reson. 98, 207-216.